SID 2026Abstract 0467Clinical trial
UAZ22-10-01: A phase IIa single-arm open-label clinical trial of calcipotriene plus 5-fluorouracil immunotherapy for skin cancer prevention in organ transplant recipients
Azin M, Oka T, Farokh P, Zeng Y, Hsu CP, Semenov Y, Nazarian RM, Malo J, Safa K, Curiel-Lewandrowski CN, Anadkat MJ, Kulkarni RP, House M, Bauman JE, Thompson PA, Wojtowicz M, Demehri S
SID Annual Meeting 2026Interventional researchChicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Skin cancer & tumorsImmunosuppressed & transplantTopical treatmentsCancer drugs
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.498 · Not in PubMed: details from Crossref